144 related articles for article (PubMed ID: 10610733)
1. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
Staessen JA; Birkenhäger WH; Fagard RH
Eur Heart J; 2000 Jan; 21(1):2-7. PubMed ID: 10610733
[No Abstract] [Full Text] [Related]
2. Treatment of hypertensive patients with diabetes.
Pahor M; Psaty BM; Furberg CD
Lancet; 1998 Mar; 351(9104):689-90. PubMed ID: 9504510
[No Abstract] [Full Text] [Related]
3. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
Califf RM; Granger CB
Diabetes Care; 1998 Apr; 21(4):655-7. PubMed ID: 9571359
[No Abstract] [Full Text] [Related]
4. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
[TBL] [Abstract][Full Text] [Related]
5. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
7. [Intima-media thickness in hypertensive patients. Calcium blockers controls atherosclerosis].
MMW Fortschr Med; 2002 Jan; 144(1-2):66-7. PubMed ID: 11847890
[No Abstract] [Full Text] [Related]
8. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T
Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772
[TBL] [Abstract][Full Text] [Related]
9. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
[TBL] [Abstract][Full Text] [Related]
10. [Calcium antagonist against hypertension. Arteriosclerosis controlled].
MMW Fortschr Med; 2002 Oct; 144(42):63. PubMed ID: 12534002
[No Abstract] [Full Text] [Related]
11. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Tatti P; Pahor M; Byington RP; Di Mauro P; Guarisco R; Strollo G; Strollo F
Diabetes Care; 1998 Apr; 21(4):597-603. PubMed ID: 9571349
[TBL] [Abstract][Full Text] [Related]
12. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Iwasaka T
J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
[TBL] [Abstract][Full Text] [Related]
13. Treatment of diabetic patients with hypertension.
Birkenhäger WH; Staessen JA
Curr Hypertens Rep; 1999 Jun; 1(3):225-31. PubMed ID: 10981070
[TBL] [Abstract][Full Text] [Related]
14. [Novel actions of calcium channel blockers].
Kumagai H; Onami T; Takimoto C; Iigaya K; Hayashi K
Nihon Rinsho; 2006 Aug; 64 Suppl 6():311-7. PubMed ID: 16983770
[No Abstract] [Full Text] [Related]
15. The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies.
Pahor M; Tatti P
Am J Cardiol; 1999 Mar; 83(5):819-20. PubMed ID: 10080455
[No Abstract] [Full Text] [Related]
16. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
[No Abstract] [Full Text] [Related]
17. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
[TBL] [Abstract][Full Text] [Related]
18. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertensive patients with diabetes: beyond blood pressure control and focus on manidipine.
Saiz Satjes M; Martinez-Martin FJ
Future Cardiol; 2016 Jul; 12(4):435-47. PubMed ID: 27221471
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyridine calcium channel blockers and the progression of parkinsonism.
Marras C; Gruneir A; Rochon P; Wang X; Anderson G; Brotchie J; Bell CM; Fox S; Austin PC
Ann Neurol; 2012 Mar; 71(3):362-9. PubMed ID: 22451203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
